Search research articles
Contact Us
Filters
Showing results (111-120 of 130) with videos related to
Page
of 13
Sort By:
The Oncologist
|
July 6, 2024
Prediction of moderate and severe toxicities of chemotherapy in older patients with cancer: a propensity weighted analysis of ELCAPA cohort
Marc-Antoine Benderra, Elena Paillaud, Amaury Broussier, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
July 30, 2017
Expression, Biochemistry, and Stabilization with Camel Antibodies of Membrane Proteins: Case Study of the Mouse 5-HT3 Receptor
Ghérici Hassaïne, Cédric Deluz, Luigino Grasso, et al.
Cytotherapy
|
August 1, 2020
Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers
Chloé Talarmin, Steven Kerob, François Cartier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 30, 2025
Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective study
Elisabeth Ashton, Nicolas Delanoy, Rym El Gharib, et al.
Eclinicalmedicine
|
April 13, 2026
A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort study
Laurine Mebarki, Elise Andre, Fabien Subtil, et al.
Bone Marrow Transplantation
|
January 30, 2022
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma
Raphaël Liévin, Roberta Di Blasi, Florence Morin, et al.
Frontiers in Immunology
|
March 11, 2021
Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers
Ismaïl Hendaoui, Ahlem Lahmar, Luca Campo, et al.
Oncotarget
|
May 19, 2016
De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas
Sihem Mebarki, Romain Désert, Laurent Sulpice, et al.
Therapie
|
December 19, 2023
What should be done to combat misinformation about health products?
Joëlle Micallef, Hervé Maisonneuve, Sophie Muller, et al.
Therapie
|
November 20, 2023
Joëlle Micallef, Hervé Maisonneuve, Sophie Muller, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 130) with videos related to
Sort By:
Page
of 13
The Oncologist
|
July 6, 2024
Prediction of moderate and severe toxicities of chemotherapy in older patients with cancer: a propensity weighted analysis of ELCAPA cohort
Marc-Antoine Benderra, Elena Paillaud, Amaury Broussier, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
July 30, 2017
Expression, Biochemistry, and Stabilization with Camel Antibodies of Membrane Proteins: Case Study of the Mouse 5-HT3 Receptor
Ghérici Hassaïne, Cédric Deluz, Luigino Grasso, et al.
Cytotherapy
|
August 1, 2020
Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers
Chloé Talarmin, Steven Kerob, François Cartier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 30, 2025
Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective study
Elisabeth Ashton, Nicolas Delanoy, Rym El Gharib, et al.
Eclinicalmedicine
|
April 13, 2026
A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort study
Laurine Mebarki, Elise Andre, Fabien Subtil, et al.
Bone Marrow Transplantation
|
January 30, 2022
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma
Raphaël Liévin, Roberta Di Blasi, Florence Morin, et al.
Frontiers in Immunology
|
March 11, 2021
Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers
Ismaïl Hendaoui, Ahlem Lahmar, Luca Campo, et al.
Oncotarget
|
May 19, 2016
De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas
Sihem Mebarki, Romain Désert, Laurent Sulpice, et al.
Therapie
|
December 19, 2023
What should be done to combat misinformation about health products?
Joëlle Micallef, Hervé Maisonneuve, Sophie Muller, et al.
Therapie
|
November 20, 2023
Joëlle Micallef, Hervé Maisonneuve, Sophie Muller, et al.
Page
of 13